Both in Pharmaceuticals
ArriVent BioPharma vs Design Therapeutics
Over the past year AVBP returned −24.1% and DSGN returned +55.0%; their daily moves had a correlation of 0.23.
AVBP −24.1% DSGN +55.0%Growth of $1, one year, split-adjusted
| Metric | AVBP | DSGN |
|---|---|---|
| Price | $13.35 | $10.15 |
| Market cap | $658.3M | $635.2M |
| Today | −10.22% | −4.96% |
| 1 month | −52.8% | −17.7% |
| 6 months | −56.1% | −22.9% |
| Year to date | −33.6% | +8.2% |
| 1 year | −27.7% | +55.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $373.1M | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | 154.4% | 55.4% |
| Short % of float | 20.3% | 21.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).